Interesting:
Note: Remyelination is the regeneration of myelin after it had been degraded in some way.
2 Likes
Interesting, thanks for sharing!
There was a Clinical Trial ending in 2022…Opicinumab…relating to Multiple Sclerosis
It was discontinued…
Limitations and Caveats
The top-line results from the Part 1 did not meet the pre-specified primary endpoint nor the key secondary endpoints. The decision to discontinue study 215MS202 Part 2 was not based on safety concerns.
1https://clinicaltrials.gov/search?intr=Opicinumab